Skip to content
Clinical Trials – home
SpainBack to Spain

Clinical trials in Ferrol – page 5

60 clinical trials in Ferrol, Spain. Every trial is listed in the EU Clinical Trials Register and updated daily.

SpainOur site in SpainEnsayosClinicos.es(opens in a new tab)
Ferrol at a glance
60
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

60 trials in Ferrol

Open in trial search

Crohn's disease

Not recruiting

Study on the Effectiveness and Safety of Risankizumab for Patients with Moderate to Severe Crohn's Disease

Investigational
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Risankizumab
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Colitis ulcerative

Not recruiting

Study on the Effectiveness and Safety of Risankizumab for Patients with Moderate to Severe Ulcerative Colitis

Investigational
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Risankizumab
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Obesity+1

Not recruiting

Study of LY3502970 for Adults with Obesity or Overweight and Related Health Issues

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Sponsor:Eli Lilly & Co.

Atrial fibrillation+2

Not recruiting

Study on Asundexian and Apixaban for Preventing Stroke in Adults with Atrial Fibrillation at Risk for Stroke

Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Apixaban
  • Sponsor:Bayer AG

Obesity+2

Not recruiting

Study of Retatrutide (LY3437943) for Patients with Obesity or Overweight and Knee Osteoarthritis

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:LY3437943 sodium
  • Sponsor:Eli Lilly & Co.

Study on Preventing Blood Clots with Tinzaparin in Patients with Metastatic Colorectal Cancer Starting First-Line Treatment

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Tinzaparin Sodium
  • Sponsor:Grupo Gallego De Investigacion En Tumores Digestivos

Colitis ulcerative

Not recruiting

Study on the Effectiveness and Safety of JNJ-77242113 for Patients with Moderate to Severe Ulcerative Colitis

Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Azathioprine
  • Sponsor:Janssen Cilag International

Dyslipidaemia

Not recruiting

Study on the Effects of AZD0780 on Cholesterol Levels in Adults Aged 18-75 with Dyslipidemia

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:1-[6-[[(1S,3S)-3-[[5-(Difluoromethoxy)Pyrimidin-2-Yl]Amino]Cyclopentyl]Amino]Pyridin-3-Yl]Pyridin-2-One
  • Sponsor:AstraZeneca AB

Colitis ulcerative

Not recruiting

Study on the Effects of Obefazimod for Patients with Moderate to Severe Ulcerative Colitis

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Obefazimod
  • Sponsor:Abivax
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Risankizumab
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Cardiovascular disorder+1

Not recruiting

Study on the Effects of Retatrutide for Patients with Severe Obesity and Cardiovascular Disease

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:LY3437943 sodium
  • Sponsor:Eli Lilly & Co.

Crohn's disease

Not recruiting

Study on Guselkumab for Healing in Crohn's Disease Patients

InvestigationalNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Guselkumab
  • Sponsor:Janssen Cilag International

Other cities in Spain

The busiest research cities in the country

All 218 cities in Spain

Clinical research in Ferrol

What the registry says about research in the country

01 Metabolic Disorders

Clinical research focusing on innovative treatments for Type 2 Diabetes and obesity management. Studies evaluate new insulin formulations and novel therapeutic approaches for weight management.

  • Diabetes management strategies
  • Weight loss interventions
  • Metabolic health optimization

Multiple trials exploring dual-action medications targeting both obesity and associated conditions.

02 Gastrointestinal Diseases

Comprehensive research into inflammatory bowel conditions, including Ulcerative Colitis and Crohn's Disease. Studies focus on novel therapeutic agents and treatment approaches.

  • Advanced biologics testing
  • Long-term disease management
  • Pediatric treatment options

Innovative therapies being evaluated for both induction and maintenance of remission.

03 Cardiovascular Health

Studies targeting cardiovascular disease prevention and treatment, including research on stroke prevention in atrial fibrillation and atherosclerosis management.

  • Heart failure treatments
  • Stroke prevention strategies
  • Hypertension management

Focus on both preventive measures and therapeutic interventions for various cardiac conditions.

04 Renal Studies

Investigation of treatments for chronic kidney disease, including both diabetic and non-diabetic conditions. Research evaluates novel therapeutic combinations and standalone treatments.

  • Kidney disease progression
  • Combination therapy approaches
  • Albumin reduction strategies

Emphasis on delaying disease progression and improving outcomes in kidney disorders.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.